haloperidol has been researched along with Myoclonic Jerk in 18 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient had unusual, life-threatening complications, consisting of cardiac arrhythmia, followed by cardiac arrest, dysphagia persisting for eight weeks and leading to aspiration pneumonia, seizures, and myoclonus following treatment with haloperidol." | 7.66 | Neuroleptic malignant syndrome after haloperidol therapy. ( Cruz, FG; Harney, JH; Thiagarajan, D, 1983) |
| "From among 1377 patients with movement disorders, four patients had an unusual movement disorder characterised by paroxysmal bursts of involuntary, regular, repetitive, rhythmic, bilateral, coordinated, simultaneous, stereotypic myoclonus and vocalisations, often associated with tonic symptoms, interference with voluntary functioning, presence of hyperactivity, attention and learning disabilities, and resistance to treatment with haloperidol and other drugs." | 3.67 | Paroxysmal myoclonic dystonia with vocalisations: new entity or variant of preexisting syndromes? ( Feinberg, TE; Shapiro, AK; Shapiro, E, 1986) |
| " The patient had unusual, life-threatening complications, consisting of cardiac arrhythmia, followed by cardiac arrest, dysphagia persisting for eight weeks and leading to aspiration pneumonia, seizures, and myoclonus following treatment with haloperidol." | 3.66 | Neuroleptic malignant syndrome after haloperidol therapy. ( Cruz, FG; Harney, JH; Thiagarajan, D, 1983) |
| "Haloperidol has long been used to manage agitation in dementia, but it is associated with increased side effects." | 1.35 | Multifocal myoclonus induced by haloperidol. ( Benito-León, J; Bermejo-Pareja, F; Domínguez, C, 2009) |
| "The pattern of myoclonus is unlike previous reported cases and may relate to activation of serotonin 5HT1A receptors (possibly supersensitive in Pick's disease) or to hypodopaminergia." | 1.29 | Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease. ( Lauterbach, EC, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Hayase, T | 1 |
| Saiga, H | 1 |
| Yamaguchi, T | 1 |
| Domínguez, C | 1 |
| Benito-León, J | 1 |
| Bermejo-Pareja, F | 1 |
| Vural, A | 1 |
| Tezer, FI | 1 |
| Lenders, MW | 1 |
| Buschman, HP | 1 |
| Vergouwen, MD | 1 |
| Steur, EN | 1 |
| Kölling, P | 1 |
| Hariz, M | 1 |
| Cruz, FG | 1 |
| Thiagarajan, D | 1 |
| Harney, JH | 1 |
| D'Souza, DC | 1 |
| Bennett, A | 1 |
| Abi-Dargham, A | 1 |
| Krystal, JH | 1 |
| Lauterbach, EC | 1 |
| Iakimovskiĭ, AF | 1 |
| Weiner, WJ | 1 |
| Carvey, PM | 1 |
| Nausieda, PA | 1 |
| Klawans, HL | 2 |
| Dzoljic, MR | 1 |
| van der Lely, AJ | 1 |
| von Mourik, JB | 1 |
| Greer, CA | 1 |
| Alpern, HP | 1 |
| Avakian, RM | 1 |
| Feinberg, TE | 1 |
| Shapiro, AK | 1 |
| Shapiro, E | 1 |
| Carvey, P | 1 |
| Paulseth, JE | 1 |
| Goetz, CG | 1 |
| Marsden, CD | 1 |
| Bieger, D | 1 |
| Larochelle, L | 1 |
| Hornykiewicz, O | 1 |
| Traczyńska-Kubin, H | 1 |
| Matkowska, L | 1 |
| Lhermitte, F | 1 |
| Peterfalvi, M | 1 |
| Marteau, R | 1 |
| Gazengel, J | 1 |
| Serdaru, M | 1 |
18 other studies available for haloperidol and Myoclonic Jerk
| Article | Year |
|---|---|
Haloperidol-induced myoclonus in a patient with delirium.
Topics: Antipsychotic Agents; Delirium; Haloperidol; Humans; Myoclonus | 2023 |
Multifocal myoclonus induced by haloperidol.
Topics: Alzheimer Disease; Antipsychotic Agents; Female; Haloperidol; Humans; Middle Aged; Myoclonus | 2009 |
Myoclonus induced by haloperidol in the intensive care unit.
Topics: Aged, 80 and over; Dopamine Antagonists; Dyspnea; Electroencephalography; Haloperidol; Heart Failure | 2012 |
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.
Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Com | 2005 |
Neuroleptic malignant syndrome after haloperidol therapy.
Topics: Deglutition Disorders; Haloperidol; Heart Arrest; Humans; Male; Middle Aged; Myoclonus; Pneumonia, A | 1983 |
Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
Topics: Akathisia, Drug-Induced; Drug Therapy, Combination; Fluoxetine; Haloperidol; Humans; Male; Middle Ag | 1994 |
Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease.
Topics: Affective Disorders, Psychotic; Brain; Dementia; Dose-Response Relationship, Drug; Electroencephalog | 1994 |
[The effect of the activation and blockade of the neostriatal dopaminergic system on the hyperkinesis evoked in rats by the intrastriatal administration of picrotoxin].
Topics: Amphetamine; Animals; Chorea; Haloperidol; Hyperkinesis; Male; Metoclopramide; Microinjections; Myoc | 1993 |
Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Dopamine Antagonists; Ergolines; Guinea Pigs; Haloperidol | 1979 |
Enkephalin-induced myoclonic twitches blocked by ergometrine and potentiated by haloperidol.
Topics: Animals; Drug Synergism; Endorphins; Enkephalins; Ergonovine; Female; Haloperidol; Male; Myoclonus; | 1979 |
Mediation of myoclonic seizures by dopamine and clonic seizures by acetylcholine and GABA.
Topics: Animals; Apomorphine; Bicuculline; Dose-Response Relationship, Drug; Flurothyl; Haloperidol; Isoquin | 1977 |
[Effect of striatectomy on the course of corazole seizures in rats].
Topics: Animals; Apomorphine; Chlorpromazine; Corpus Striatum; Electroencephalography; Female; Haloperidol; | 1976 |
Paroxysmal myoclonic dystonia with vocalisations: new entity or variant of preexisting syndromes?
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Dystonia; Female; Haloperidol; Humans; Male; Move | 1986 |
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Bromocriptine; Clonazepam; Disease Models, Animal; Guinea | 1986 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; My | 1973 |
A model for the quantitative study of central dopaminergic and serotoninergic activity.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Caudate Nucleus; Chlorpromazine; Dihydroxyphenylalanine; | 1972 |
[Diagnosis and treatment of myoclonic syndromes in children].
Topics: Adolescent; Barbiturates; Child; Child, Preschool; Diazepam; Female; Haloperidol; Humans; Male; Myoc | 1973 |
[Pharmacological analysis of a case of postanoxic intention and action myoclonus].
Topics: 5-Hydroxytryptophan; Alcohols; Anticonvulsants; Benzoates; Carbamazepine; Chlorpromazine; Diazepam; | 1971 |